Dr. Estey's research focus is on optimizing clinical trial methodology so that the design is more in keeping with the complexities of medical practice — for example, monitoring multiple endpoints, such as survival and toxicity, rather than just one endpoint. The second area is enhancing the treatment of AML and myelodysplastic syndromes by collecting and analyzing data, so that care decisions are always based on evidence rather than convention.
Seattle Cancer Care Alliance, Fred Hutchinson Research Center: 1354 Aloha St, Seattle, WA 98109, USA
Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life
Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia
Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.